Trials / Completed
CompletedNCT02544802
Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee
Treatment of Primary Osteoarthritis of the Knee Joint With Autologous Mesenchymal Stem Cells
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Steminent Biotherapeutics Inc. · Industry
- Sex
- All
- Age
- 50 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of autologous adipose-derived mesenchymal stem cells (ADMSCs) treatment for patients with primary osteoarthritis knee. Three intra-articular injections of autologous ADMSCs will be performed to subjects at a weekly interval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adipose-Derived Mesenchymal Stem Cells |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2019-01-31
- Completion
- 2019-01-31
- First posted
- 2015-09-09
- Last updated
- 2022-10-28
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02544802. Inclusion in this directory is not an endorsement.